Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is McDonald’s Corporation (MCD)’s Cooked… Or Serving Up More Dividends?

Page 1 of 3

We keep hearing about the demise of McDonald’s Corporation (NYSE:MCD). Now, there’s no doubt that the company has faced some challenges lately. Labor disputes, currency effects, questions over the food quality and nutrition, and changing consumer tastes have all coalesced to put the company – and its stock – in a precarious position.

McDonald's Corporation (NYSE:MCD)

Same-store sales are down regularly and marketing initiatives haven’t connected well with consumers. But let’s not forget that this is a $91 billion company that franchises and operates a combined 36,000+ restaurants across 125 countries. Let’s also not forget that people have to eat. As long as McDonald’s continues to conveniently provide good food at a great value, they’ll very likely continue to sell billions of dollars’ worth of cheeseburgers, fries, and beverages.

So let’s talk about that demise. What does that demise look like for the stock? Well, first the long-term performance: McDonald’s total return over the last 10 years is an annualized 16.64%. That obviously trounces SPY’s 10-year annualized 7.71%.

Short term? The stock is up 1.46% YTD. The S&P 500 is roughly flat. So that’s the demise of MCD’s stock. We now see that there’s perhaps just a little hyperbole involved there.

What about the company’s performance? That’s ultimately what matters most. Stock prices go up and down, but long-term business performance is what will ultimately drive returns. And it’s growing earnings that will fuel growing dividends. Using that same 10-year time frame as above, we can see revenue grew from $20.460 billion to $27.441 billion from fiscal years 2005 to 2014. That’s a compound annual growth rate of 3.32%.

Top-line growth isn’t particularly impressive, though the company is a victim of its own success: It’s somewhat difficult to grow from such a large base, especially at a meaningful rate. But per-share profit growth is more impressive. earnings-per-share increased from $2.04 to $4.82 over this period, which is a compound annual growth rate of 10.02%. However, growth over the last five years has slowed markedly.

Improving margins and a substantial reduction of the outstanding share count drove a lot of that additional bottom-line growth. Shares outstanding have been reduced by over 20% over the last decade. That means there’s 20% less shares across which to spread out the remaining profit.

S&P Capital IQ anticipates that earnings-per-share will grow at a 7% compound annual rate over the next three years, which, while lower than what we saw over the last decade, is nowhere near a company on the brink of failure. That’s still a pretty solid growth rate. However, what makes this stock really attractive right now is the 3.6% yield. That’s about 160 basis points higher than the broader market – a significant difference. Add that 3.58% yield to the 7% expected underlying EPS growth, and you have the recipe for pretty solid returns moving forward.

Page 1 of 3

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!